Compare Manchester United PLC (MANU) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Manchester United (MANU) trades at $20.25, down 0.74% on the day, amid a bearish technical signal. The company reported a net loss of $33.02 million for 2025 despite revenue of $666.51 million, with negative profit margins and return metrics. Recent news highlights a valuation gap, with the market cap at $3.6 billion versus a Forbes estimate of $7.2 billion, while operational performance shows some improvement with a return to Champions League football.

The outlook remains cautious; while the valuation discount presents a potential opportunity, persistent losses and high debt levels pose significant risks. Analyst sentiment is mixed with a 40% buy rating, but fundamental challenges in achieving sustained profitability are key concerns for investors.

DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.

The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.